Global Biodegradable Stents Market 2016 – Medicines Co., Xenogenics Corporation, ELLA-CS s.r.o., Medtronic Inc., Tepha Inc., Ethicon, Inc., Reva Medical Inc., Eurocor GmbH, Kyoto Medical Planning Co. Ltd., Poly-Med Inc.

Biodegradable Stents Market 2016This study gives an insight into Global Stents and Biodegradable Stents market. The report also provides an overview of the Worldwide Bare Metal Stents and Drug Eluting Stents market. Market analytics for Biodegradable Stents by Application and by Biodegradable Material is provided in this niche report. The market is divided by Application into Coronary Arterial Stents, Peripheral Arterial Stents and Other; and by Biodegradable Material into Polymer and Metal. Global stents market is analyzed from 2005 -2015, while estimations and predictions for biodegradable stents market are provided from 2015-2020.

Global biodegradable stents market is projected to grow at a whopping CAGR 70.10% during the analysis period 2015-2020.

Major Companies profiled in this research report: Medicines Co. (The) (USA), Xenogenics Corporation (USA), ELLA-CS, s.r.o. (Czech Republic), Medtronic, Inc. (USA), Tepha, Inc. (USA), Ethicon, Inc. (USA), Reva Medical Inc. (USA), Eurocor GmbH (Germany), Kyoto Medical Planning Co., Ltd. (Japan), Poly-Med, Inc. (USA), JMS Co., Ltd. (Japan)

Request For Free Report Sample @

Europe, following North America, is projected as the second largest market for Biodegradable Stents. Bioresorbable polymeric stents have become popular alternative for metallic stents as these can remain in situ for a predetermined period of time, these keep the wall of the blood vessel intact and ultimately disintegrates to non-toxic substances. A major part of the problems related to the metal stents are solved with this stent. There is evidence to support the fact that the use of bioresorbable coronary stent reduces the necessity for a substitute part after half a year. The use of bioresorbable stents is advocated in such cases where removal surgery is difficult. For e.g. in case of treatment of tracheomalacia in newborns and infants.

Key market dynamics are provided for North America, Europe, Asia-Pacific, and Rest of World (RoW). Business profiles of 25 biodegradable stents companies are discussed in the report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.

Enquiry About This Report @

Leave a Reply

Your email address will not be published. Required fields are marked *